← All stocks

Traws Pharma, Inc.

TRAW Net buying
CIK 0001130598 #5313 in the set updated 18 Sep 2026
Bought (120 mo)
$12.49M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$1.64M
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$1.64M
26 of 26 sales
Net
+$10.85M
+$10.85M against sales at will

By person

26 insiders · 76 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
TYNDALL CAPITAL PARTNERS L P entity
10% owner
$5.42M (2)
$352.49K (12)
+$5.07M
616,389
$1.03M
683 Capital Management, LLC entity
Former 10% Owner
$5.24M (2)
$1.03M (5)
+$4.21M
460,000
$768.20K
ORBIMED ADVISORS LLC entity
10% owner
$998.21K (1)
+$998.21K
1,203,250
$2.01M
+98.7%
Reddy E Premkumar
Director
$350.00K (3)
$143.95K (1)
+$206.05K
16,683
$27.86K
MARINO JAMES J
Director
$126.62K (8)
+$126.62K
21,334
$35.63K
Hoffman Michael B
Director
(1)
$95.32K (6)
−$95.32K
5,753,600
$9.61M
+50.4%
Fruchtman Steven M
PRESIDENT, CHIEF EXECUTIVE OFF
$80.02K (5)
+$80.02K
74,792
$124.90K
OLER ABRAHAM N.
SVP Corp Dev & Gen Counsel
$72.85K (11)
+$72.85K
24,514
$40.94K
Kumar Ramesh
Chief Executive Officer
$50.00K (1)
+$50.00K
102,227
$170.72K
+30.4%
MEHTA VIREN
Director
$50.00K (1)
+$50.00K
250,967
$419.11K
+25,853%
Guerin Mark Patrick
Chief Financial Officer
$48.62K (6)
+$48.62K
39,255
$65.56K
Shoemaker Mary Teresa
Director
$23.00K (2)
+$23.00K
6,292
$10.51K
ARMISTICE CAPITAL, LLC entity
10% owner
$13.02K (2)
−$13.02K
1,633,404
$2.73M
−0.6%
Bienen Henry S
Director
$11.80K (2)
+$11.80K
22,724
$37.95K
+154.9%
Gelder Mark S. MD
CHIEF MEDICAL OFFICER
$10.00K (1)
+$10.00K
10,487
$17.51K
GROOPMAN JEROME
Director
$3.63K (1)
+$3.63K
10,001
$16.70K
+1,000,000%
STOVER JACK E
Director
(1)
$0.00
6,165
$10.30K
Dukes Iain D.
Chief Executive Officer
1,816,230
$3.03M
Savchuk Nikolay
Chief Operating Officer
1,795,706
$3.00M
Pauza Charles David
Chief Science Officer Virology
115,971
$193.67K
Redfield Robert
Chief Medical Officer
113,919
$190.24K
CAUTREELS WERNER
Director
109,222
$182.40K
Parker Charles Nolan
Chief Financial Officer
15,393
$25.71K
Clarke Trafford
Director
6,157
$10.28K
Leaman John Harold
Director
4,058
$6.78K
TPAV, LLC entity
10% owner
0
$0.00
−100.0%

No percentages here. This company's share count has moved by a factor of 5.1 over the window, from 3,025,554 to 15,368,277 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
ORBIMED ADVISORS LLC
16 Apr 2026
10% owner
Buy indirect
597,729
$1.67
$998.21K
OLER ABRAHAM N.
28 Jan 2022
SVP Corp Dev & Gen Counsel
Buy
1,500
$1.67
$2.51K
OLER ABRAHAM N.
21 Jan 2022
SVP Corp Dev & Gen Counsel
Buy
1,500
$2.02
$3.03K
OLER ABRAHAM N.
14 Jan 2022
SVP CORP DEV & GEN COUNSEL
Buy
1,500
$2.20
$3.30K
OLER ABRAHAM N.
7 Jan 2022
SVP Corp Dev & Gen Counsel
Buy
1,500
$2.39
$3.59K
OLER ABRAHAM N.
19 Nov 2021
SVP CORP DEV & GEN COUNSEL
Buy
1,000
$3.16
$3.16K
MARINO JAMES J
28 Sep 2021
Director
Buy
5,952
$4.20
$25.00K
Fruchtman Steven M
28 Sep 2021
President, Chief Executive Off
Buy
2,381
$4.20
$10.00K
Gelder Mark S. MD
28 Sep 2021
Chief Medical Officer
Buy
2,381
$4.20
$10.00K
OLER ABRAHAM N.
28 Sep 2021
SVP Corp Dev & Gen Counsel
Buy
2,381
$4.20
$10.00K
Shoemaker Mary Teresa
16 Feb 2021
Director
Buy
13,000
$1.00
$13.00K
MARINO JAMES J
16 Feb 2021
Director
Buy
25,000
$1.00
$25.00K
Fruchtman Steven M
16 Feb 2021
President, Chief Executive Off
Buy
20,000
$1.00
$20.00K
Guerin Mark Patrick
16 Feb 2021
Chief Financial Officer
Buy
15,000
$1.00
$15.00K
OLER ABRAHAM N.
16 Feb 2021
SVP Corp Dev & Gen Counsel
Buy
12,000
$1.00
$12.00K
OLER ABRAHAM N.
11 Dec 2020
SVP Corp Dev & Gen Counsel
Buy
30,000
$0.32
$9.60K
Guerin Mark Patrick
27 Nov 2020
Chief Financial Officer
Buy
4,614
$0.26
$1.20K
Fruchtman Steven M
25 Nov 2020
President, Chief Executive Off
Buy
40,000
$0.26
$10.36K
OLER ABRAHAM N.
25 Nov 2020
SVP Corp Dev & Gen Counsel
Buy
20,000
$0.26
$5.12K
Guerin Mark Patrick
25 Nov 2020
Chief Financial Officer
Buy
16,755
$0.26
$4.36K
Shoemaker Mary Teresa
25 Nov 2020
Director
Buy
37,735
$0.27
$10.00K
MARINO JAMES J
24 Nov 2020
Director
Buy
38,774
$0.26
$10.00K
Fruchtman Steven M
19 May 2020
President, Chief Executive Off
Buy
26,800
$0.37
$9.86K
Guerin Mark Patrick
19 May 2020
Chief Financial Officer
Buy
21,000
$0.36
$7.56K
OLER ABRAHAM N.
19 May 2020
SVP Corp Dev & Gen Counsel
Buy
15,000
$0.37
$5.55K
GROOPMAN JEROME
19 May 2020
Director
Buy
10,000
$0.36
$3.63K
OLER ABRAHAM N.
25 Nov 2019
VP Corp Dev & Gen Counsel
Buy
75,000
$0.20
$15.00K
Guerin Mark Patrick
25 Nov 2019
Chief Financial Officer
Buy
87,500
$0.20
$17.50K
Fruchtman Steven M
25 Nov 2019
President, Chief Executive Off
Buy
149,000
$0.20
$29.80K
MARINO JAMES J
25 Nov 2019
Director
Buy
150,000
$0.20
$30.00K
Reddy E Premkumar
25 Nov 2019
Director
Buy
500,000
$0.20
$100.00K
MEHTA VIREN
25 Nov 2019
Director
Buy
250,000
$0.20
$50.00K
MARINO JAMES J
25 Sep 2019
Director
Buy
7,260
$1.60
$11.62K
Bienen Henry S
29 May 2018
Director
Buy
10,000
$0.38
$3.80K
TYNDALL CAPITAL PARTNERS L P
27 Apr 2018
10% owner
Buy indirect
10,147,058
$0.43
$4.31M
683 Capital Management, LLC
27 Apr 2018
10% owner
Buy indirect
11,838,235
$0.43
$5.03M
MARINO JAMES J
27 Apr 2018
Director
Buy
58,900
no price
STOVER JACK E
27 Apr 2018
Director
Buy
47,100
no price
Hoffman Michael B
27 Apr 2018
Director
Buy indirect
2,211,765
no price
Reddy E Premkumar
27 Apr 2018
Director
Buy
282,350
no price
683 Capital Management, LLC
8 Feb 2018
10% owner
Buy indirect
200,000
$1.04
$207.12K
MARINO JAMES J
8 Feb 2018
Director
Buy
50,000
no price
TYNDALL CAPITAL PARTNERS L P
8 Feb 2018
10% owner
Buy indirect
1,100,000
$1.01
$1.11M
Kumar Ramesh
26 Apr 2017
President and CEO
Buy
23,810
$2.10
$50.00K
Reddy E Premkumar
26 Apr 2017
Director
Buy
119,048
$2.10
$250.00K
MARINO JAMES J
26 Apr 2017
Director
Buy
11,906
$2.10
$25.00K
Guerin Mark Patrick
26 Apr 2017
Chief Financial Officer
Buy
1,429
$2.10
$3.00K
Bienen Henry S
26 Apr 2017
Director
Buy
3,810
$2.10
$8.00K

What was left out

Form 4 filings counted 224
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 6
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 26
Transactions with no price 5
Shares from compensation/vesting 6,347,647
Sales filed before the plan box existed 26
History held since 1 Sep 2016